RxNorm 2688133 NDC Crossover
influenza virus vaccine 2024-2025 (trivalent - Georgia/Sydney/Singapore) Injectable
Related NDC Codes to RxNorm Concept 2688133
The following NDC codes crossover to the RxNorm Concept 2688133. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
|---|---|---|---|---|---|---|---|
| 70461-554 | Flucelvax | Influenza A Virus A/georgia/12/2022 Crv-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/sydney/1304/2022 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Inc. | ACTIVE | |
| 70461-654 | Flucelvax | Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/sydney/1304/2022 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated) | Injection, Suspension | Intramuscular | Seqirus Inc. | ACTIVE |
